170 related articles for article (PubMed ID: 19015455)
1. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.
Liu Z; Hartman YE; Warram JM; Knowles JA; Sweeny L; Zhou T; Rosenthal EL
Mol Cancer Res; 2011 Aug; 9(8):1008-17. PubMed ID: 21665938
[TBL] [Abstract][Full Text] [Related]
3. EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts.
Newman JR; Helman EE; Safavy S; Zhang W; Rosenthal EL
Cancer Lett; 2009 Feb; 274(2):313-8. PubMed ID: 18990485
[TBL] [Abstract][Full Text] [Related]
4. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.
Dean NR; Newman JR; Helman EE; Zhang W; Safavy S; Weeks DM; Cunningham M; Snyder LA; Tang Y; Yan L; McNally LR; Buchsbaum DJ; Rosenthal EL
Clin Cancer Res; 2009 Jun; 15(12):4058-65. PubMed ID: 19509148
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
Rosenthal EL; Vidrine DM; Zhang W
Laryngoscope; 2006 Jul; 116(7):1086-92. PubMed ID: 16826041
[TBL] [Abstract][Full Text] [Related]
6. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Suzuki S; Ishikawa K
Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
[TBL] [Abstract][Full Text] [Related]
8. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma.
Knowles JA; Golden B; Yan L; Carroll WR; Helman EE; Rosenthal EL
Laryngoscope; 2011 Nov; 121(11):2359-65. PubMed ID: 22020886
[TBL] [Abstract][Full Text] [Related]
11. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
13. The role of MAGEA2 in head and neck cancer.
Glazer CA; Smith IM; Bhan S; Sun W; Chang SS; Pattani KM; Westra W; Khan Z; Califano JA
Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):286-93. PubMed ID: 21422315
[TBL] [Abstract][Full Text] [Related]
14. Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model.
Dean NR; Knowles JA; Helman EE; Aldridge JC; Carroll WR; Magnuson JS; Clemons L; Ziober B; Rosenthal EL
Anticancer Drugs; 2010 Oct; 21(9):861-7. PubMed ID: 20700044
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
Zhang W; Matrisian LM; Holmbeck K; Vick CC; Rosenthal EL
BMC Cancer; 2006 Mar; 6():52. PubMed ID: 16515711
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo.
Yang X; Zhang P; Ma Q; Kong L; Li Y; Liu B; Lei D
Cancer Biol Ther; 2012 Jan; 13(2):85-91. PubMed ID: 22198615
[TBL] [Abstract][Full Text] [Related]
17. Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147.
Newman JR; Gleysteen JP; Barañano CF; Bremser JR; Zhang W; Zinn KR; Rosenthal EL
Cancer Biol Ther; 2008 Jul; 7(7):1063-70. PubMed ID: 18431087
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Steiner GE; Rockwell P; Gedlicka C; Burian M
Laryngoscope; 2001 Oct; 111(10):1834-41. PubMed ID: 11801954
[TBL] [Abstract][Full Text] [Related]
19. Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.
Abraham D; Zins K; Sioud M; Lucas T; Aharinejad S
Front Biosci; 2008 May; 13():5571-9. PubMed ID: 18508606
[TBL] [Abstract][Full Text] [Related]
20. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
